🔎 Trials Near Me

Domov › Meduloblastom › Florida

Klinične študije za Meduloblastom v Florida

6 študij za Meduloblastom išče udeležence na lokacijah v Florida.

Mesta v Florida

Uradno besedilo študije (angleško)

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

  • Orlando Health Arnold Palmer Hospital for Children, Orlando
  • St. Joseph's Children's Hospital, Tampa
Vključevanje udeležencevFaza 2
59 Months · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT05535166

Digoxin Medulloblastoma Study

  • Nemours Jacksonville, Jacksonville
  • University of Miami, Miami
  • Johns Hopkins All Children's, St. Petersburg
  • in še 1
Vključevanje udeležencevFaza 2
12 Months – 30 Years · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT06701812

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
  • Nemours Children's Clinic-Jacksonville, Jacksonville
  • in še 7
Vključevanje udeležencevFaza 3
Starost 4–21 · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT05382338

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Nicklaus Children's Hospital, Miami
Vključevanje udeležencevFaza 2
Starost 3–39 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT05096481

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

  • Nicklaus Children's Hospital, Miami
  • Arnold Palmer Hospital for Children, Orlando
  • All Children's Hospital Johns Hopkins Medicine, St. Petersburg
  • in še 1
Vključevanje udeležencevFaza 2
Do 21 let · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT04696029

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

  • University of Florida Health, Gainesville
Vključevanje udeležencevFaza 1
Starost 4–30 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06514898

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.